More than a quarter of people with Type 2 diabetes take GLP-1 receptor agonists, but the popular diabetes drugs might not work as well for people who have certain genetic variants, according to a new study by Stanford Medicine scientists and their collaborators
A population-based approach to integrated healthcare delivery: a scoping review of clinical care and public health collaboration
10.1016/j.ejphar.2010.09.009 144 TremoliE.GhiselliG.MadernaP.ColliS.SirtoriC
2 BPC157) 2 BPC157) 2 BPC157) Claims (15) A salt of a BPC (Body Protection Compound) said peptide being constituted of 8 to 15 amino acids, peptide wherein the anion of the salt is a negatively charged peptide comprising 8 amino acid residues having the general formula Xaa is a neutral aliphatic amino acid residue, Yaa is a basic amino acid residue and Zaa is an acidic amino acid residue, and wherein the cation of the salt is the cation of an inorganic or organic non-toxic base
Data were expressed as percentages and converted to absolute numbers of phagocytosing PMN and PBMC using the results of automated cell counting
Data are presented as the mean (SEM) from five animals per treatment group and are representative of three independent experiments